360 related articles for article (PubMed ID: 33884540)
1. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
4. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness.
Golyan FF; Abbaszadegan MR; Forghanifard MM
J Cell Biochem; 2019 Sep; 120(9):14838-14846. PubMed ID: 31016793
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.
Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR
Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371
[TBL] [Abstract][Full Text] [Related]
6. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
7. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
[TBL] [Abstract][Full Text] [Related]
8. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
10. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
12. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
13. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.
Fardi Golyan F; Forghanifard MM
Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
15. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
16. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
18. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Gene Expr Patterns; 2020 Sep; 37():119127. PubMed ID: 32711119
[TBL] [Abstract][Full Text] [Related]
19. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
